Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.40 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL28145190 | 1.00 | SPHK1 (0.44) | SPHK1EPHX1SPHK2CASP2DPP7 | |
| SCHEMBL1428105 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL45011 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| SCHEMBL4111428 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| SCHEMBL5133441 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| SCHEMBL245909 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| SCHEMBL3921623 | 0.98 | EPHX1 (0.47) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| Polihexanide SCHEMBL115297 | 0.96 | SPHK1 (0.49) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| Hydrochloric Acid SCHEMBL1900717 | 0.96 | SPHK1 (0.49) | SPHK1EPHX1SPHK2CASP2MEN1 | |
| Hydrochloric Acid SCHEMBL8898546 | 0.96 | SPHK1 (0.49) | SPHK1EPHX1SPHK2CASP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111773439-B | Biological friendly antibacterial coating capable of effectively fixing cationic antibacterial agent and resisting bacterial biofilm | 陕西师范大学 | 2022-03-04 | — | — | CN | claimed |
| CN-111773439-A | Biological friendly antibacterial coating capable of effectively fixing cationic antibacterial agent and resisting bacterial biofilm | 陕西师范大学 | 2020-10-16 | — | — | CN | claimed |
| CN-106340386-B | A kind of large capacity thin film capacitor | 安徽飞达电气科技有限公司 | 2018-06-01 | — | — | CN | claimed |
| CN-106340386-A | High-capacity film capacitor | 安徽飞达电气科技有限公司 | 2017-01-18 | — | — | CN | claimed |
| US-20160160447-A1 | Guanidyl Paper Coating | Polymer Ventures Inc. (US) | 2016-06-09 | — | — | US | claimed |
| US-8631868-B1 | Treatment of subterranean formations | Polymer Ventures Inc. (US) | 2014-01-21 | — | — | US | claimed |
| US-8220565-B1 | Treatment of subterranean formations | POLYMER VENTURES, INC. (US) | 2012-07-17 | — | — | US | claimed |
| US-20120160485-A1 | Treatment of Subterranean Formations | POLYMER VENTURES, INC. (US) | 2012-06-28 | — | — | US | claimed |
| EP-1670645-B1 | BIGUANIDE BLEACHING AGENT FOR THERMAL-IMAGING | EASTMAN KODAK CO (US) | 2012-05-02 | — | — | EP | claimed |
| US-8157010-B2 | Treatment of subterranean formations | POLYMER VENTURES, INC. (US) | 2012-04-17 | — | — | US | claimed |
| US-20120067585-A1 | TREATMENT OF SUBTERRANEAN FORMATIONS | WATER MARK TECHNOLOGIES, INC. (US) | 2012-03-22 | — | — | US | claimed |
| CN-1730725-B | Surface treatment method for flux-brazed aluminum-made heat exchanger | NIPPON PAINT CO LTD | 2010-06-23 | — | — | CN | claimed |
| US-7172992-B2 | Biguanide bleaching agent for a thermal-imaging receptor element | EASTMAN KODAK COMPANY (US) | 2007-02-06 | — | — | US | claimed |
| EP-1670645-A1 | BIGUANIDE BLEACHING AGENT FOR A THERMAL-IMAGING RECEPTOR ELEMENT | Kodak Polychrome Graphics (US) | 2006-06-21 | — | — | EP | claimed |
| US-20050181943-A1 | Biguanide bleaching agent for a thermal-imaging receptor element | KODAK POLYCHROME GRAPHICS LLC (US) | 2005-08-18 | — | — | US | claimed |
| WO-2005030492-A1 | BIGUANIDE BLEACHING AGENT FOR A THERMAL-IMAGING RECEPTOR ELEMENT | KODAK POLYCHROME GRAPHICS LLC (US) | 2005-04-07 | — | — | WO | claimed |
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | ANJI PHARMACEUTICALS INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | ANJI PHARMACEUTICALS INC. (US) | 2023-09-19 | — | — | US | disclosed |
| EP-0225852-A2 | Processing holograms | ILFORD Limited (GB) | 1987-06-16 | — | — | EP | disclosed |
| EP-0225853-A2 | Holograms | ILFORD Limited (GB) | 1987-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11759441-B2 | Biguanide compositions and methods of treating metabolic disorders | SLC5A2, SLC5A1, GPR119 | SPHK1 1998/4885EPHX1 2097/4885SPHK2 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.